(AIP) Arteris - Ratings and Ratios
NoC IP, Integration Software, Consulting
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 78.6% |
| Value at Risk 5%th | 108% |
| Relative Tail Risk | -16.60% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.79 |
| Alpha | 11.09 |
| CAGR/Max DD | 1.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.525 |
| Beta | 2.098 |
| Beta Downside | 2.160 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.48% |
| Mean DD | 20.10% |
| Median DD | 19.74% |
Description: AIP Arteris December 28, 2025
Arteris Inc. (NASDAQ:AIP) designs and licenses semiconductor-system IP that orchestrates on-chip communication for System-on-Chip (SoC) and chiplet architectures. Its product portfolio includes the FlexGen/FlexNoC/FlexWay non-coherent Network-on-Chip (NoC) family, the cache-coherent Ncore NoC, the CodaCache last-level cache, and integration-automation tools such as Magillem and CSRCompiler. The company also monetizes professional services, licensing, and support across automotive, communications, enterprise computing, consumer electronics, and industrial markets.
Key market signals that could affect Arteris’ growth trajectory include: (1) the accelerating adoption of chiplet-based designs, which the industry estimates will capture ≈ 30 % of new high-performance SoC launches by 2026, expanding the addressable TAM for NoC IP; (2) its FY 2024 revenue of ≈ $115 million, reflecting a ≈ 22 % YoY increase driven largely by automotive and data-center customers; and (3) a rising R&D intensity, with R&D expenses representing ≈ 15 % of revenue, underscoring the need to stay ahead of competing IP providers such as Arm and Synopsys. These drivers are balanced against macro-level semiconductor cyclicality and the company’s reliance on a limited number of large licensees.
For a deeper quantitative assessment, the ValueRay platform provides a concise, data-driven view of Arteris’ valuation metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-34.4m TTM) > 0 and > 6% of Revenue (6% = 3.96m TTM) |
| FCFTA -0.00 (>2.0%) and ΔFCFTA 1.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -12.48% (prev 10.74%; Δ -23.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 932.0k > Net Income -34.4m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (42.7m) change vs 12m ago 8.77% (target <= -2.0% for YES) |
| Gross Margin 89.98% (prev 89.34%; Δ 0.64pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.18% (prev 56.02%; Δ 8.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -159.2 (EBITDA TTM -25.9m / Interest Expense TTM 184.0k) >= 6 (WARN >= 3) |
Altman Z'' -8.79
| (A) -0.08 = (Total Current Assets 58.5m - Total Current Liabilities 66.8m) / Total Assets 107.7m |
| (B) -1.51 = Retained Earnings (Balance) -163.1m / Total Assets 107.7m |
| warn (B) unusual magnitude: -1.51 — check mapping/units |
| (C) -0.29 = EBIT TTM -29.3m / Avg Total Assets 102.7m |
| (D) -1.37 = Book Value of Equity -162.8m / Total Liabilities 119.2m |
| Total Rating: -8.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.74
| 1. Piotroski 3.0pt |
| 2. FCF Yield -0.06% |
| 3. FCF Margin -0.56% |
| 4. Debt/Equity -0.60 |
| 5. Debt/Ebitda 0.41 |
| 7. RoE 551.4% |
| 8. Rev. Trend 80.66% |
| 9. EPS Trend 51.26% |
What is the price of AIP shares?
Over the past week, the price has changed by +12.62%, over one month by -3.30%, over three months by +29.46% and over the past year by +43.16%.
Is AIP a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AIP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18.1 | 3.1% |
| Analysts Target Price | 18.1 | 3.1% |
| ValueRay Target Price | 19.3 | 9.6% |
AIP Fundamental Data Overview January 03, 2026
P/S = 10.2698
P/B = 56.0391
Beta = 1.487
Revenue TTM = 65.9m USD
EBIT TTM = -29.3m USD
EBITDA TTM = -25.9m USD
Long Term Debt = 624.0k USD (from longTermDebt, last quarter)
Short Term Debt = 2.80m USD (from shortTermDebt, last quarter)
Debt = 6.86m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.7m USD (from netDebt column, last quarter)
Enterprise Value = 644.9m USD (677.1m + Debt 6.86m - CCE 39.1m)
Interest Coverage Ratio = -159.2 (Ebit TTM -29.3m / Interest Expense TTM 184.0k)
FCF Yield = -0.06% (FCF TTM -372.0k / Enterprise Value 644.9m)
FCF Margin = -0.56% (FCF TTM -372.0k / Revenue TTM 65.9m)
Net Margin = -52.25% (Net Income TTM -34.4m / Revenue TTM 65.9m)
Gross Margin = 89.98% ((Revenue TTM 65.9m - Cost of Revenue TTM 6.61m) / Revenue TTM)
Gross Margin QoQ = 89.86% (prev 89.44%)
Tobins Q-Ratio = 5.99 (Enterprise Value 644.9m / Total Assets 107.7m)
Interest Expense / Debt = 0.71% (Interest Expense 49.0k / Debt 6.86m)
Taxrate = -4.41% (negative due to tax credits) (380.0k / -8.61m)
NOPAT = -30.6m (EBIT -29.3m * (1 - -4.41%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.88 (Total Current Assets 58.5m / Total Current Liabilities 66.8m)
Debt / Equity = -0.60 (negative equity) (Debt 6.86m / totalStockholderEquity, last quarter -11.4m)
Debt / EBITDA = 0.41 (negative EBITDA) (Net Debt -10.7m / EBITDA -25.9m)
Debt / FCF = 28.65 (negative FCF - burning cash) (Net Debt -10.7m / FCF TTM -372.0k)
Total Stockholder Equity = -6.25m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.97% (Net Income -34.4m / Total Assets 107.7m)
RoE = 551.4% (negative equity) (Net Income TTM -34.4m / Total Stockholder Equity -6.25m)
RoCE = 521.0% (negative capital employed) (EBIT -29.3m / Capital Employed (Equity -6.25m + L.T.Debt 624.0k))
RoIC = -3444 % (out of range, set to none) (NOPAT -30.6m / Invested Capital 888.0k)
WACC = 13.61% (E(677.1m)/V(684.0m) * Re(13.74%) + D(6.86m)/V(684.0m) * Rd(0.71%) * (1-Tc(-0.04)))
Discount Rate = 13.74% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.20%
Fair Price DCF = unknown (Cash Flow -372.0k)
EPS Correlation: 51.26 | EPS CAGR: 41.94% | SUE: 4.0 | # QB: 1
Revenue Correlation: 80.66 | Revenue CAGR: 11.86% | SUE: 1.26 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.06 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=-0.14 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+61.0% | Growth Revenue=+20.2%
Additional Sources for AIP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle